Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6586413

Methods and compositions for reducing ischemic injury of the heart by administering adenos

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6582699

Combination vaccine for enhancing immunity against brucellosis

Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence in her Brittanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583271

Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for impro

The Regents of the University of California · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583164

Antimycotic drug composition

Takeda Chemical Industries Ltd. · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583146

Thiazolopyrimidine compounds, its production and use

Takeda Chemical Industries Ltd. · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583145

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6582697

Enhancement of the cellular immune response

Biomira, Inc. · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6583143

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6579674

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6579857

Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576786

Process for preparing substituted cyclopentane derivatives and novel crystalline structure

BioCryst Pharmaceuticals, Inc. · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576764

Synthesis and crystallization of piperazine ring-containing compounds

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576234

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576676

Means for the modulation of processes mediated by retinold receptors and compounds useful

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576155

Fluorescent ink compositions comprising functionalized fluorescent nanocrystals

BioCrystal, Ltd. · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576262

Methods and apparatus for particle formation

Nektar Therapeutics · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576440

Methods and compositions for wound healing

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576609

Methods and compositions for generating angiostatin

Northwestern University · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6573289

Naphthalene derivatives, their production and use

Takeda Chemical Industries Ltd. · Granted Tue Jun 03 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6569661

Recombinant &agr;-L-iduronidase, methods for producing and purifying the same and methods

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6569995

Identification of a G protein-coupled receptor transcriptionally regulated by protein tyro

The Regents of the University of California · Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6569406

Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation

Nektar Therapeutics · Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6569459

Method of administration of paclitaxel-plasma protein formulation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566509

Multivalent macrolide antibiotics

Theravance, Inc. · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired